Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
A major feature of Alzheimer's disease is the accumulation of β-amyloid (Aβ) peptide in the brain. Recent studies have indicated that Aβ oligomers (Aβo) can interact with the cellular prion protein (PrPc). Therefore, this interaction might be driving some of Aβ toxic effects in the synaptic region. In the present study, we report that Aβo binds to PrPc in the neuronal membrane playing a role on toxic effects induced by Aβ. Phospholipase C-enzymatic cleavage of PrPc from the plasma membrane attenuated the association of Aβo to the neurons. Furthermore, an anti-PrP antibody (6D11) decreased the association of Aβo to hippocampal neurons with a concomitant reduction in Aβo and PrPc co-localization. Interestingly, this antibody blocked the increase in membrane conductance and intracellular calcium induced by Aβo. Thus, the data indicate that PrPc plays a role on the membrane perforations produced by Aβo, the increase in calcium ions and the release of synaptic vesicles that subsequently leads to synaptic failure. Future studies blocking Aβo interaction with PrPc could be important for the discovery of new therapeutic strategies for Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911829107 · Cited by 466
Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
Research works printed but not linked: 31
- Aguayo, 1994, Ethanol modulation of the gamma-aminobutyric acidA- and glycine-activated Cl- current in cultured mouse neurons, J. Pharmacol. Exp. Ther., 270, 61, 10.1016/S0022-3565(25)22381-3 · DOI · Paper page
- Arispe, 2008, Efficiency of histidine-associating compounds for blocking the Alzheimer's Abeta channel activity and cytotoxicity, Biophys. J., 95, 4879, 10.1529/biophysj.108.135517 · doi:10.1529/biophysj.108.135517
- Arispe, 2002, Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides, FASEB J., 16, 1526, 10.1096/fj.02-0829com · DOI · Paper page
- Avila, 2010, Canonical Wnt3a modulates intracellular calcium and enhances excitatory neurotransmission in hippocampal neurons, J. Biol. Chem., 285, 18939, 10.1074/jbc.M110.103028 · DOI · Paper page
- Bate, 2010, Phospholipase A2 inhibitors protect against prion and Aβ mediated synapse degeneration, Mol. Neurodegeneration, 5, 13, 10.1186/1750-1326-5-13 · DOI
- Berr, 2003, Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing, Acta Neuropathol., 106, 71, 10.1007/s00401-003-0700-7 · DOI
- Chen, 2010, Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues, J. Biol. Chem., 285, 26377, 10.1074/jbc.M110.145516 · DOI · Paper page
- Chung, 2010, Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse, BMC Neurosci., 11, 130, 10.1186/1471-2202-11-130 · DOI · Paper page
- Cohen, 1998, Pathologic conformations of prion proteins, Annu. Rev. Biochem., 67, 793, 10.1146/annurev.biochem.67.1.793 · DOI · Paper page
- Demuro, 2005, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem., 280, 17294, 10.1074/jbc.M500997200 · DOI · Paper page
- Demuro, 2013, Cytotoxicity of intracellular abeta42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate, J. Neurosci., 33, 3824, 10.1523/JNEUROSCI.4367-12.2013 · DOI · Paper page
- Demuro, 2011, Single-channel Ca2+ imaging implicates A 1-42 amyloid pores in Alzheimer's disease pathology, J. Cell Biol., 195, 515, 10.1083/jcb.201104133 · DOI · Paper page
- Freir, 2011, Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites, Nat. Commun., 2, 336, 10.1038/ncomms1341 · DOI · Paper page
- Fu, 2003, Amyloid peptide activates non-7 nicotinic acetylcholine receptors in rat basal forebrain neurons, J. Neurophysiol., 90, 3130, 10.1152/jn.00616.2003 · DOI
- Gimbel, 2010, Memory impairment in transgenic Alzheimer mice requires cellular prion protein, J. Neurosci., 30, 6367, 10.1523/JNEUROSCI.0395-10.2010 · DOI · Paper page
- Gunther, 2010, Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease, J. Mol. Med. (Berl), 88, 331, 10.1007/s00109-009-0568-7 · DOI
- Kakio, 2001, Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid, J. Biol. Chem., 276, 24985, 10.1074/jbc.M100252200 · DOI · Paper page
- Kovacs, 2002, The prion protein in human neurodegenerative disorders, Neurosci. Lett., 329, 269, 10.1016/S0304-3940(02)00668-7 · DOI
- Parodi, 2009, Amyloid causes depletion of synaptic vesicles leading to neurotransmission failure, J. Biol. Chem., 285, 2506, 10.1074/jbc.M109.030023 · DOI · Paper page
- Peters, 2013, Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide, Neurobiol. Aging, 34, 2805, 10.1016/j.neurobiolaging.2013.06.001 · DOI · Paper page
- Peters, 2011, Biphasic effects of copper on neurotransmission in rat hippocampal neurons, J. Neurochem., 119, 78, 10.1111/j.1471-4159.2011.07417.x · DOI · Paper page
- Prusiner, 1998, The prion diseases, Brain Pathol., 8, 499, 10.1111/j.1750-3639.1998.tb00171.x · DOI · Paper page
- Schwarze-Eicker, 2005, Prion protein (PrPc) promotes beta-amyloid plaque formation, Neurobiol. Aging, 26, 1177, 10.1016/j.neurobiolaging.2004.10.004 · DOI
- Selkoe, 2002, Alzheimer's disease is a synaptic failure, Science, 298, 789, 10.1126/science.1074069 · DOI · Paper page
- Sepulveda, 2014, Nature of the neurotoxic membrane actions of amyloid-beta on hippocampal neurons in Alzheimer's disease, Neurobiol. Aging, 35, 472, 10.1016/j.neurobiolaging.2013.08.035 · DOI
- Sepulveda, 2010, Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property, PLoS One, 5, e11820, 10.1371/journal.pone.0011820 · DOI · Paper page
- Stahl, 1990, Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C, Biochemistry, 29, 5405, 10.1021/bi00474a028 · DOI · Paper page
- Tarsa, 2002, Synaptophysin regulates activity-dependent synapse formation in cultured hippocampal neurons, Proc. Natl. Acad. Sci. U. S. A., 99, 1012, 10.1073/pnas.022575999 · DOI · Paper page
- Texido, 2011, Amyloid beta peptide oligomers directly activate NMDA receptors, Cell Calcium, 49, 184, 10.1016/j.ceca.2011.02.001 · DOI · Paper page
- Um, 2012, Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons, Nat. Neurosci., 15, 1227, 10.1038/nn.3178 · DOI · Paper page
- Zou, 2011, Amyloid- 42 interacts mainly with insoluble prion protein in the Alzheimer brain, J. Biol. Chem., 286, 15095, 10.1074/jbc.M110.199356 · DOI · Paper page
Cited by
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870
Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373
“Interestingly, exposure to AβOs recruits PrPC molecules to the neuronal surface (Caetano et al., 2011), consistent with functional interaction between oligomers and PrPC triggering signaling pathways to causememory impairment (Gimbel et al., 2010; Um et al., 2012, 2013; Peters et al., 2015).”
BackgroundAstrogliosis: An integral player in the pathogenesis of Alzheimer's disease
Osborn, L. M., Kamphuis, W., Wadman, W. J., & Hol, E. M. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.001 · Cited by 312
Amyloid-β oligomers in cellular models of Alzheimer’s disease
Fontana, I. C., Zimmer, A. R., Rocha, A. S., Gosmann, G., Souza, D. O., Lourenco, M. V., Ferreira, S. T., & Zimmer, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15030 · Cited by 115
Hales, C. M., Dammer, E. B., Deng, Q., Duong, D. M., Gearing, M., Troncoso, J. C., Thambisetty, M., Lah, J. J., Shulman, J. M., Levey, A. I., et al. (2016) · PROTEOMICS · doi:10.1002/pmic.201600057 · Cited by 99
Metadata
- Authors
- Peters, C., Espinoza, M. P., Gallegos, S., Opazo, C., & Aguayo, L. G.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 36
- Issue
- 3
- Pages
- 1369-1377
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2152011177
- Cited by
- 55
- References
- 4
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- FONDECYT (1100502, 1140473)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2014.11.019
- The paper
- Peters, C., Espinoza, M. P., Gallegos, S., Opazo, C., & Aguayo, L. G. (2015). Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2014.11.019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.